D. Baltas

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
D Baltas, D. Baltas, Dimos Baltas
Publication record
311 papers · 5,655 citations · H-index 42

PAPERS

Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation
202413 citationsauthor #4
Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis
20243 citationsauthor #5
The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy
20243 citationsauthor #5
The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT
20244 citationsauthor #9
Evaluation of RADIANCE Monte Carlo algorithm for treatment planning in electron based Intraoperative Radiotherapy (IOERT)
20241 citationsauthor #6
Free automatic software for quality assurance of computed tomography calibration, edges and radiomics metrics reproducibility.
20232 citationsauthor #8
Photon-counting computed tomography of coronary and peripheral artery stents: a phantom study
202316 citationsauthor #8
Recurrence Analysis of Glioblastoma Cases Based on Distance and Dose Information.
202312 citationsauthor #6
Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking
202212 citationsauthor #5
Comparison of protocols with respiratory-gated (4D) motion compensation in PET/CT: open-source package for quantification of phantom image quality
20222 citationsauthor #6
Determination of the dose rate around a HDR 192Ir brachytherapy source with the microDiamond and the microSilicon detector
20227 citationsauthor #7
Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients
20224 citationsauthor #5
OC-0627 TCP predictions of an automated dose painting strategy based on FDG and FMISO PET imaging
20220 citationsauthor #6
Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis
20226 citationsauthor #8
PO-1414 Results of a concept-development for a phase III trial on radiotherapy in primary prostate cancer
20220 citationsauthor #18
Implementation of PSMA-PET in focal dose-escalated radiotherapy of primary prostate cancer patients: Results of a planned safety analysis of a phase II trial.
20220 citationsauthor #9
HYPOXIA-BASED ADAPTIVE TREATMENT PLANNING: THE IMPACT OF THE IMAGE REGISTRATION METHOD
20220 citationsauthor #6
The use of deep learning in interventional radiotherapy (brachytherapy): A review with a focus on open source and open data
20225 citationsauthor #3
PD-0581 Offline-adaptive planning of mpMRI- and PSMA-PET- based dose escalation: results of a phase II trial
20220 citationsauthor #6
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation
20222 citationsauthor #10
Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses
202221 citationsauthor #9
18F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
202133 citationsauthor #12
PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
202140 citationsauthor #14
Vision, Development, and Structure of the First German Specialist Training Curriculum for Radiology
202111 citationsauthor #29
PSMA-PET- and mpMRI-guided focal radiation dose escalation in primary prostate cancer patients – a planned safety analysis of a two-armed prospective phase II trial (HypoFocal)
20210 citationsauthor #9
PO-1348 Urethral sparing increases the therapeutic ratio in dose escalated hypofractionated radiotherapy
20210 citationsauthor #12
Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer
20217 citationsauthor #7
Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference
202112 citationsauthor #12
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
202128 citationsauthor #11
OC-0131 WP21 BRAPHYQS survey of differences in 192Ir and 60Co brachytherapy RAKR determinations
20210 citationsauthor #4
High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
20219 citationsauthor #5
Automatic segmentation of prostate on TRUS images using convolutional neural networks
20210 citationsauthor #6
Automatic Segmentation of Brain Structures for Treatment Planning Optimization and Target Volume Definition
20212 citationsauthor #3
Experimental phantom evaluation to identify robust positron emission tomography (PET) radiomic features
202116 citationsauthor #4
Development of a Hypoxia-Immune Prognostic Classifier for Head-and-Neck Cancer Patients Undergoing Radiotherapy - Results From a Prospective Imaging Trial.
20212 citationsauthor #7
Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial.
20218 citationsauthor #7
PD-0874 Impact of dose and prescription method in SBRT of NSCLC. A pooled analysis of 2 prospective trials.
20210 citationsauthor #12
OC-0135 GEC-ESTRO / ACROP recommendations for Quality Assurance of Ultrasound in Brachytherapy
20210 citationsauthor #4
OC-0629 A hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing radiotherapy
20210 citationsauthor #7
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
202136 citationsauthor #9
Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates
20219 citationsauthor #4
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial
20215 citationsauthor #9
PH-0217 Synergistic use of combined FDG and FMISO PET/CT imaging for personalized dose prescription
20210 citationsauthor #6
PO-1524: FET-PET radiomics predicting outcome after re-irradiation in recurrent glioblastoma
20200 citationsauthor #8
PO-1541: Predictive treatment planning with SIP (simultaneously integrated protection) based on TCP and NTCP
20200 citationsauthor #2
Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition
20202 citationsauthor #6
Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial
202025 citationsauthor #7
Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation
202022 citationsauthor #7
GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy.
202022 citationsauthor #4
PO-1172: dose effects due to interfractional variability for hypofractionated radiotherapy of prostate cancer
20200 citationsauthor #8
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network
202056 citationsauthor #21
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.
202031 citationsauthor #10
Measuring breathing induced oesophageal motion and its dosimetric impact
20201 citationsauthor #4
Convolutional neural network based deep-learning architecture for intraprostatic tumour contouring on PSMA PET images in patients with primary prostate cancer
20203 citationsauthor #21
PO-1556: 4D-PET radiomics-features for radiotherapy treatment monitoring in locally advanced NSCLC patients
20200 citationsauthor #7
OC-0583: Time evolution of the hypoxic compartment on sequential FMISO PET images
20200 citationsauthor #8
Dosimetric Impact of the Positional Imaging Frequency for Hypofractionated Prostate Radiotherapy – A Voxel-by-Voxel Analysis
20204 citationsauthor #10
PO-1035: Central hepatobiliary toxicity after liver SBRT and hypo-fractionated Radiotherapy
20200 citationsauthor #6
PO-1733: Validation of PSMA-PET/CT based contouring techniques for intraprostatic tumor definition
20200 citationsauthor #3
Quantification of Tumor Oxygenation Based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference Region.
20209 citationsauthor #8
Suitability of the microDiamond detector for experimental determination of the anisotropy function of High Dose Rate 192 Ir brachytherapy sources.
20206 citationsauthor #5
Evaluation with heterogeneous experimental phantoms of the impact of the intrinsic PET/CT system resolution on the robustness of radiomics-features: digital versus analog PET
20200 citationsauthor #2
PO-1695: The utility of multiparametric MRI to characterize hypoxic tumor subvolumes compared to FMISO PET/CT
20200 citationsauthor #9
Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition
20208 citationsauthor #6
PO-1653: Dosimetric effects of interfractional variations in prostate cancer radiotherapy
20200 citationsauthor #9
One-Shot Learning for Deformable Medical Image Registration and Periodic Motion Tracking
2019104 citationsauthor #2
PET Image features for their use in Radiomics: selection criteria based on intrinsic complementarity with respect to volume and robustness with respect to system, metal artefacts and voxel size in image reconstruction
20193 citationsauthor #2
Dosimetric Impact of Interfractional Variations for Post-prostatectomy Radiotherapy to the Prostatic Fossa—Relevance for the Frequency of Position Verification Imaging and Treatment Adaptation
20197 citationsauthor #9
EP-1915 Modelling framework for FMISO and FDG PET imaging tailored dose prescription
20190 citationsauthor #3
SP-0233 Optimal use of inverse optimization in brachytherapy
20190 citationsauthor #1
Radiomic Features from PSMA PET for Intraprostatic Tumor Discrimination and Characterization in Patients with Prostate Cancer. a Comparison Study with Histology Reference
20190 citationsauthor #9
Investigating the role of constrained CVT and CVT in HIPO inverse planning for HDR brachytherapy of prostate cancer.
20194 citationsauthor #5
Monte Carlo and experimental high dose rate 192Ir brachytherapy dosimetry with microDiamond detectors.
201912 citationsauthor #7
Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme
20195 citationsauthor #7
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference
2019118 citationsauthor #13
Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience.
20199 citationsauthor #3
OC-0162 PSMA PET/CT for intraprostatic tumor delineation and characterization based on radiomic features
20190 citationsauthor #13
EP-1528 Feasibility and toxicity of focal dose escalation on multimodally defined GTVs in prostate cancer
20190 citationsauthor #8
Dosimetric Impact of Interfractional Variations in Prostate Cancer Radiotherapy—Implications for Imaging Frequency and Treatment Adaptation
201921 citationsauthor #9
EP-2091: Complementarity of PET-texture features with respect to information given by conventional indexes
20180 citationsauthor #4
EP-2237: Employing the microDiamond detector for radial dose function measurements with an 192Ir HDR source
20180 citationsauthor #7
Influence of inhomogeneous radiosensitivity distributions and intrafractional organ movement on the tumour control probability of focused IMRT in prostate cancer.
20184 citationsauthor #8
Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer.
201816 citationsauthor #9
Biological imaging for individualized therapy in radiation oncology: part II medical and clinical aspects.
20188 citationsauthor #12
The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer
20180 citationsauthor #12
CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience
201815 citationsauthor #8
Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference
201861 citationsauthor #15
Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference
20180 citationsauthor #15
PO-0819: High dose rate brachytherapy plus external beam radiotherapy for localized prostate cancer
20180 citationsauthor #8
Significance of the impact of motion compensation on the variability of PET image features
201823 citationsauthor #4
Biological imaging for individualized therapy in radiation oncology: part I physical and technical aspects.
20182 citationsauthor #7
Inverse planning and inverse implanting for breast interstitial brachytherapy. Introducing a new anatomy specific breast interstitial template (ASBIT).
20181 citationsauthor #12
PO-0930: Influence of inhomogeneous radiosensitivity and intrafractional movement on TCP in prostate cancer
20180 citationsauthor #8
Mathematical Description of Changes in Tumour Oxygenation from Repeated Functional Imaging.
20181 citationsauthor #4
EP-2258: HIPO inverse planning utilizing constrained CVT for HDR brachytherapy of prostate cancer
20180 citationsauthor #2
PO-0818: Focal IMRT dose escalation for prostate cancer using PSMA PET/CT and MRI: a planning study
20181 citationsauthor #12
The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer
201823 citationsauthor #12
High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status.
201750 citationsauthor #3
EP-1698: Impact of motion and segmentation on PET texture features: evaluation with heterogeneous phantoms.
20170 citationsauthor #3
Comparison of PSMA-PET/CT and Multiparametric MRI for Dose Painting Guidance in Patients With Primary Prostate Cancer Based on Comparison with Histology Reference
20170 citationsauthor #12

TIMELINE

1989 6 citations

1993 3 citations

1994 0 citations

1995 0 citations

1997 39 citations

1998 357 citations

1999 219 citations

2000 401 citations

2001 453 citations

2002 248 citations

2003 478 citations

2004 403 citations

2005 203 citations

2006 228 citations

2007 191 citations

2008 56 citations

2009 190 citations

2010 98 citations

2011 146 citations

2012 36 citations

2013 291 citations

2014 326 citations

2016 65 citations

2017 267 citations

2018 155 citations

2019 283 citations

2020 189 citations

2021 218 citations

2022 59 citations

2023 30 citations

2024 24 citations

D. Baltas

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT